ZIVO Bioscience, Inc. (ZIVO)
USD 19.25
(-3.7%)
USD 19.25
(-3.7%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -5.79 Million | -7.1 Million | -6.8 Million | -2.58 Million | -3.7 Million | -5 Million |
| Net Income | -7.77 Million | -8.74 Million | -9.16 Million | -9.1 Million | -11.51 Million | -14.63 Million |
| Depreciation & Amortization | 439.59 Thousand | -774.02 Thousand | -555.74 Million | - | 1.18 Million | 5.09 Million |
| Deferred income taxes | -498.68 Thousand | - | 555.74 Million | - | -3.6 Million | - |
| Stock-based compensation | 867.35 Thousand | 2.69 Million | 2.97 Million | 1.24 Million | 3.6 Million | 1.39 Million |
| Change in working capital | 1.28 Million | -355.39 Thousand | -394.12 Thousand | 2.66 Million | 2.46 Million | 1.92 Million |
| Other non-cash items | -111.64 Thousand | 79.63 Thousand | -623.35 Thousand | 2.59 Million | 4.14 Million | 2.6 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 4.27 Million | -628.6 Thousand | 15.56 Million | 2.38 Million | 3.66 Million | 5.07 Million |
| Debt repayment | -1.75 Million | -628.6 Thousand | -190.5 Thousand | -250.7 Thousand | -32.5 Thousand | -217.61 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 640 Thousand | - | 17.2 Million | 400.86 Thousand | 2.65 Million | 3.43 Million |
| Other Financing Activities | 5.39 Million | 628.6 Thousand | -1.45 Million | 1.97 Million | 3.66 Million | 1.86 Million |
| Accounts receivables | -3735.00 | - | - | - | - | - |
| Accounts payables | 675.09 Thousand | -163.66 Thousand | -905.29 Thousand | 187.19 Thousand | 950 Thousand | -119.28 Thousand |
| Inventory | 1.1 Million | - | - | - | - | - |
| Other working capital | -498.68 Thousand | -191.73 Thousand | 511.16 Thousand | 2.48 Million | 1.51 Million | 2.04 Million |
| Cash at beginning of period | 1.79 Million | 8.9 Million | 137.86 Thousand | 346.11 Thousand | 388.89 Thousand | 317.13 Thousand |
| Cash at end of period | 274.38 Thousand | 1.79 Million | 8.9 Million | 137.86 Thousand | 346.11 Thousand | 388.89 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.52 Million | -7.1 Million | 8.76 Million | -208.24 Thousand | -42.78 Thousand | 71.75 Thousand |
| Free Cash Flow | -5.79 Million | -7.1 Million | -6.8 Million | -2.58 Million | -3.7 Million | -5 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.23 Million | -1.27 Million | -7.77 Million | -1.9 Million | -1.82 Million | -2.07 Million |
| Depreciation & Amortization | - | - | 439.59 Thousand | 709.83 Thousand | - | -270.23 Thousand |
| Deferred income taxes | - | - | -498.68 Thousand | -270.23 Thousand | - | 270.23 Thousand |
| Stock-based compensation | 7.54 Million | 112.1 Thousand | 867.35 Thousand | 156.69 Thousand | 240.75 Thousand | 227.8 Thousand |
| Change in working capital | 37.74 Thousand | -557.29 Thousand | 1.28 Million | 1.08 Million | -438.59 Thousand | 929.13 Thousand |
| Other non-cash items | 25.31 Thousand | 24.55 Thousand | -111.64 Thousand | -48.51 Thousand | 53.25 Thousand | -72.03 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 487.47 Thousand | 1.56 Million | 4.27 Million | -494.53 Thousand | 3.43 Million | 798.13 Thousand |
| Debt repayment | -172.52 Thousand | -460.05 Thousand | -1.75 Million | -1.28 Million | -201.86 Thousand | -201.86 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 659.99 Thousand | 1.1 Million | 640 Thousand | 485 Thousand | - | - |
| Other Financing Activities | - | 648.34 Thousand | 5.39 Million | 790.04 Thousand | 3.63 Million | 1 Million |
| Accounts receivables | - | - | -3735.00 | -1142.00 | 363.00 | -2956.00 |
| Accounts payables | 255.86 Thousand | -248.74 Thousand | 675.09 Thousand | 774.62 Thousand | -573.86 Thousand | 294.71 Thousand |
| Inventory | - | - | 1.1 Million | -2956.00 | - | 2956.00 |
| Other working capital | -218.12 Thousand | - | -498.68 Thousand | 311.14 Thousand | 134.9 Thousand | 634.41 Thousand |
| Cash at beginning of period | 138.64 Thousand | 274.38 Thousand | 1.79 Million | 1.48 Million | 21.06 Thousand | 208.6 Thousand |
| Cash at end of period | 2466.00 | 138.64 Thousand | 274.38 Thousand | 274.38 Thousand | 1.48 Million | 21.06 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -136.17 Thousand | -135.73 Thousand | -1.52 Million | -1.21 Million | 1.46 Million | -187.53 Thousand |
| Free Cash Flow | -623.65 Thousand | -1.69 Million | -5.79 Million | -715.73 Thousand | -1.96 Million | -985.66 Thousand |
LXP-PC
OPCH
150A
0888
CKISY
CYSNF